116 results on '"Imipenem -- Health aspects"'
Search Results
52. Delivery Of A Drug For Medical Use: Imipenem Tsilastatin
53. Researchers from University of Ilorin Detail New Studies and Findings in the Area of Pneumonia (Clinical and Microbiological Profile of Adult Inpatients With Community Acquired Pneumonia In Ilorin, North Central, Nigeria)
54. The Supply Of A Drug For Medical Use By Imipenem Tsilastatin
55. 2022-16770|. The Supply Of A Drug For Medical Use By Imipenem Cylastatin
56. Delivery Of Drugs For Medical Use (vancrikomin, Imipenem Cylastatin, Phosphomicin)
57. The Supply Of A Drug For Medical Use With Mnn 'imipenem Tsilastatin' (registry Number 223669)
58. Data on Health and Medicine Reported by Researchers at University of Punjab (blaOXA, blaSHV-, and blaTEM- extended-spectrum b-lactamases in Gram-negative strains from burn patients in Lahore, Pakistan)
59. New Pseudomonas aeruginosa Data Have Been Reported by Researchers at Shiraz University of Medical Sciences (Evaluating the Saliva of Burn ICU Patients for Resistant Infections Harbor Metallo-b-Lactamase Genes)
60. Recent Studies from Shiraz University of Medical Sciences Add New Data to Pseudomonas aeruginosa (Evaluating the Saliva of Burn Icu Patients for Resistant Infections Harbor Metallo-beta-lactamase Genes)
61. Data on Antibiotics Reported by Researchers at Apollo Hospitals (Surgical Site Infections Caused By Rapidly Growing Nontuberculous Mycobacteria: an Under-recognized and Misdiagnosed Entity)
62. Findings from J.A. Karlowsky and Co-Authors Provides New Data about Multidrug Resistance (In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection ...)
63. Studies from G. Shapiro and Co-Researchers Yield New Data on Abscess (A unusual case of multifocal pyogenic abscess formation following ERCP procedure)
64. Researchers at Burrell College of Osteopathic Medicine Target Epidural Abscess (T9-T10 Osteomyelitis, Epidural Abscess and Cord Compression Secondary to Mycobacterium abscessus. A Case Report)
65. New Pseudomonas aeruginosa Findings from Shiraz University of Medical Sciences Described (Evaluating the Saliva of Burn ICU Patients for Resistant Infections Harbor Metallo-b-Lactamase Genes)
66. The Supply Of Drugs For Medical Use (imipenem Tsilastatin)
67. The Supply Of A Drug For Medical Use By Imipenem Tsilastatin
68. The Supply Of Drugs For Medical Use (imipenem Tsilastatin)
69. Inter-host Transmission of Carbapenemase-Producing Escherichia coli among Humans and Backyard Animals
70. Findings from M.S. Rasool and Co-Authors Reveals New Information on Pharmaceutical Science [Prevalence and antibiotic resistance profiles of Gram negative bacilli associated with urinary tract infections (UTIs) in Karachi, Pakistan]
71. Data on Klebsiella pneumoniae Reported by Researchers at Pasteur Institute of Iran (Outbreak of hypervirulent Klebsiella pneumoniae harbouring blaVIM-2 among mechanically-ventilated drug-poisoning patients with high mortality rate in Iran)
72. Findings from University of Cairo Update Knowledge of Escherichia coli (Novel Blactx-m Variants and Genotype-phenotype Correlations Among Clinical Isolates of Extended Spectrum Beta Lactamase-producing Escherichia Coli)
73. STRATEGIES TO ADDRESS CHALLENGING OCULAR INFECTIONS: Delivering existing therapeutics through alternative routes may offer option
74. New Findings on Urinary Tract Infections Described by Investigators at Sher i Kashmir Institute of Medical Sciences (Pattern of Clinical/bacteriological Profile and Follow-up of Symptomatic Urinary Tract Infection In Patients With Diabetes: a ...)
75. Reports from University of the Punjab Provide New Insights into Gram-Negative Bacterial Infections [Detection of Carbapenemases Bla(Oxa48)-bla(Kpc)-bla(Ndm)-bla(Vim) and Extended-spectrum-beta-lactamase Bla(Oxa1)-bla(Shv)-bla(Tem) Genes In ...]
76. The road forward in the management of Acinetobacter infections in the ICU
77. Combination drug therapy on antibiotic resistance
78. Findings from Department of Microbiology Broaden Understanding of Gram-Negative Bacteria (Phenotypic and Genotypic Detection of Carbapenemase Production Among Gram Negative Bacteria Isolated From Hospital Acquired Infections)
79. De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU
80. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. (Major Article)
81. 2021-00876. Supply Of Medicines For Medical Use
82. Supply Of Medicines For Medical Use (imipenem cilastatin )
83. Bacterial Infection and Antibiotic Resistance in Patients with Human Immunodeficiency Virus Presenting Lower Respiratory Tract Infection in Nigeria
84. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam
85. Researchers at Korea University Report New Data on Colon Cancer (Disseminated Nocardiosis Caused By Nocardia Farcinica In a Patient With Colon Cancer a Case Report and Literature Review)
86. Clinical characteristics and drug sensitivity analysis of bloodstream infection caused by Klebsiella pneumoniae in the north of Henan province
87. New treatment kills off infection that can be deadly in cystic fibrosis
88. New treatment to kill infection deadly to cystic fibrosis patients
89. Mercks last-resort antibiotic Recarbrio nears EU approval
90. Pivotal RESTORE-IMI 2 Phase 3 Study of Merck's RECARBRIO[TM] (imipenem, cilastatin, and relebactam) in Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Met Primary Endpoint
91. RECON: GSK, AZ OVARIAN CANCER DRUGS REDUCE RISK OF OVARIAN CANCER RETURNING; SOBI TO BUY DOVA FOR UP TO $915M
92. United States : FDA Approves Mercks RECARBRIO (imipenem, cilastatin, and relebactam) For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited or No Alternative Treatment Options Are Avai
93. FDA Approves Merck's RECARBRIO (imipenem, cilastatin, and relebactam) For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited or No Alternative Treatment Options Are Available
94. United States : FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections
95. Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections
96. FDA APPROVES NEW TREATMENT FOR COMPLICATED URINARY TRACT AND COMPLICATED INTRA-ABDOMINAL INFECTIONS
97. U.S. FDA approves new treatment for urinary, abdominal infections
98. FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections
99. Researchers at Hainan General Hospital Target Melioidosis (Mycotic aneurysm secondary to melioidosis in China: A series of eight cases and a review of literature)
100. Researchers' Work from Shiraz University of Medical Sciences Focuses on Pseudomonas aeruginosa (Evaluating the Saliva of Burn ICU Patients for Resistant Infections Harbor Metallo-b-Lactamase Genes)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.